SAN FRANCISCO -- A new type of COVID-19 therapy is showing promise as a new tool to hijack the virus and slow down variants. It's a new weapon that could be added to the arsenal against COVID-19.

The antiviral therapy is already recommended for an estimated 3.9 million people who do not need supplemental oxygen for COVID-19 and who have an increased risk for progression to severe COVID-19.

COVID-19 is rising in prevalence in many states following the July 4 holiday week, but the role of the main therapy to treat it — the antiviral drug Paxlovid — has become less clear. Research studies ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Antiviral therapy reduced incidence of long COVID-19 ...

Viral mimic systems and other tech platforms could enable local testing of vaccine candidates and antiviral therapies. This ...

Federal budget cuts this week have undercut research at the University of Minnesota that was closing in on a better COVID-19 antiviral therapy and first-ever treatments for Ebola and other ...